- Home
- BRTX vs DFLI Comparison
BRTX vs DFLI Comparison
Compare BRTX & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- DFLI
- Stock Information
- Founded
- BRTX 1997
- DFLI 2020
- Country
- BRTX United States
- DFLI United States
- Employees
- BRTX N/A
- DFLI N/A
- Industry
- BRTX Managed Health Care
- DFLI Electronic Components
- Sector
- BRTX Health Care
- DFLI Technology
- Exchange
- BRTX Nasdaq
- DFLI Nasdaq
- Market Cap
- BRTX 12.5M
- DFLI 14.5M
- IPO Year
- BRTX N/A
- DFLI N/A
- Fundamental
- Price
- BRTX $1.66
- DFLI $1.25
- Analyst Decision
- BRTX
- DFLI Strong Buy
- Analyst Count
- BRTX 0
- DFLI 1
- Target Price
- BRTX N/A
- DFLI $1.50
- AVG Volume (30 Days)
- BRTX 74.0K
- DFLI 67.0M
- Earning Date
- BRTX 11-11-2025
- DFLI 11-13-2025
- Dividend Yield
- BRTX N/A
- DFLI N/A
- EPS Growth
- BRTX N/A
- DFLI N/A
- EPS
- BRTX N/A
- DFLI N/A
- Revenue
- BRTX $605,200.00
- DFLI $54,536,000.00
- Revenue This Year
- BRTX $232.67
- DFLI $27.77
- Revenue Next Year
- BRTX $52.92
- DFLI $42.02
- P/E Ratio
- BRTX N/A
- DFLI N/A
- Revenue Growth
- BRTX 247.62
- DFLI 4.80
- 52 Week Low
- BRTX $1.19
- DFLI $0.15
- 52 Week High
- BRTX $2.55
- DFLI $5.78
- Technical
- Relative Strength Index (RSI)
- BRTX 65.28
- DFLI 65.50
- Support Level
- BRTX $1.19
- DFLI $1.30
- Resistance Level
- BRTX $1.47
- DFLI $1.71
- Average True Range (ATR)
- BRTX 0.09
- DFLI 0.21
- MACD
- BRTX 0.02
- DFLI 0.11
- Stochastic Oscillator
- BRTX 100.00
- DFLI 49.57
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About DFLI Dragonfly Energy Holdings Corp. (NV)
Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.